Better Therapeutics CFO Mark Heinen resigns; CEO Frank Karbe takes over as principal financial officer

Better Therapeutics, Inc.

CFO Mark Heinen resigned effective Nov 27, 2023, as part of expense reduction measures.
CEO Frank Karbe assumes principal financial officer duties; controller Leslie Miller becomes principal accounting officer.
Miller receives a base salary increase and annual incentive compensation upon appointment.
Measures include voluntary salary reductions by CEO and other executives to extend cash runway for AspyreRx.
Resignation not due to any disagreement with the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Heinen

Chief Financial Officer

Better Therapeutics, Inc.

Effective: 2023-11-27
Successor: Frank Karbe
Filed: November 20, 2023, 6:59 PM ET

On November 14, 2023, Mark Heinen notified Better Therapeutics, Inc. (the “Company”) of his resignation as the chief financial officer of the Company, effective November 27, 2023.

Role change

Frank Karbe

Principal Financial Officer

Better Therapeutics, Inc.

Filed: November 20, 2023, 6:59 PM ET

Frank Karbe, the Company's chief executive officer ("CEO"), will assume the duties of principal financial officer

Role change

Leslie Miller

Principal Accounting Officer

Better Therapeutics, Inc.

Filed: November 20, 2023, 6:59 PM ET

Leslie Miller, the Company's controller, will assume the duties of principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Heinen resigned as Chief Financial Officer at Better Therapeutics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On November 14, 2023, Mark Heinen notified Better Therapeutics, Inc. (the “Company”) of his resignation as the chief financial officer of the Company, effective November 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Frank Karbe was appointed as Principal Financial Officer at Better Therapeutics, Inc..

Action: appointed
Role: Principal Financial Officer

Exact text from the filing

Frank Karbe, the Company's chief executive officer ("CEO"), will assume the duties of principal financial officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Leslie Miller was appointed as Principal Accounting Officer at Better Therapeutics, Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

Leslie Miller, the Company's controller, will assume the duties of principal accounting officer.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-23-065185

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.